- IBDEI3GW ; ; 19-NOV-2015
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,58319,1,4,0)
- ;;=4^E11.321
- ;;^UTILITY(U,$J,358.3,58319,2)
- ;;=^5002634
- ;;^UTILITY(U,$J,358.3,58320,0)
- ;;=E11.329^^272^2906^67
- ;;^UTILITY(U,$J,358.3,58320,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58320,1,3,0)
- ;;=3^Type 2 DM w/ Mild Nonprolif DM Retinopathy w/o Macular Edema
- ;;^UTILITY(U,$J,358.3,58320,1,4,0)
- ;;=4^E11.329
- ;;^UTILITY(U,$J,358.3,58320,2)
- ;;=^5002635
- ;;^UTILITY(U,$J,358.3,58321,0)
- ;;=E11.331^^272^2906^68
- ;;^UTILITY(U,$J,358.3,58321,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58321,1,3,0)
- ;;=3^Type 2 DM w/ Mod Nonprolif DM Retinopathy w/ Macular Edema
- ;;^UTILITY(U,$J,358.3,58321,1,4,0)
- ;;=4^E11.331
- ;;^UTILITY(U,$J,358.3,58321,2)
- ;;=^5002636
- ;;^UTILITY(U,$J,358.3,58322,0)
- ;;=E11.339^^272^2906^69
- ;;^UTILITY(U,$J,358.3,58322,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58322,1,3,0)
- ;;=3^Type 2 DM w/ Mod Nonprolif DM Retinopathy w/o Macular Edema
- ;;^UTILITY(U,$J,358.3,58322,1,4,0)
- ;;=4^E11.339
- ;;^UTILITY(U,$J,358.3,58322,2)
- ;;=^5002637
- ;;^UTILITY(U,$J,358.3,58323,0)
- ;;=E11.351^^272^2906^70
- ;;^UTILITY(U,$J,358.3,58323,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58323,1,3,0)
- ;;=3^Type 2 DM w/ Prolif DM Retinopathy w/ Macular Edema
- ;;^UTILITY(U,$J,358.3,58323,1,4,0)
- ;;=4^E11.351
- ;;^UTILITY(U,$J,358.3,58323,2)
- ;;=^5002640
- ;;^UTILITY(U,$J,358.3,58324,0)
- ;;=E11.359^^272^2906^71
- ;;^UTILITY(U,$J,358.3,58324,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58324,1,3,0)
- ;;=3^Type 2 DM w/ Prolif DM Retinopathy w/o Macular Edema
- ;;^UTILITY(U,$J,358.3,58324,1,4,0)
- ;;=4^E11.359
- ;;^UTILITY(U,$J,358.3,58324,2)
- ;;=^5002641
- ;;^UTILITY(U,$J,358.3,58325,0)
- ;;=E11.341^^272^2906^72
- ;;^UTILITY(U,$J,358.3,58325,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58325,1,3,0)
- ;;=3^Type 2 DM w/ Severe Nonprolif DM Retinopathy w/ Macular Edema
- ;;^UTILITY(U,$J,358.3,58325,1,4,0)
- ;;=4^E11.341
- ;;^UTILITY(U,$J,358.3,58325,2)
- ;;=^5002638
- ;;^UTILITY(U,$J,358.3,58326,0)
- ;;=E11.349^^272^2906^73
- ;;^UTILITY(U,$J,358.3,58326,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58326,1,3,0)
- ;;=3^Type 2 DM w/ Severe Nonprolif DM Retinopathy w/o Macular Edema
- ;;^UTILITY(U,$J,358.3,58326,1,4,0)
- ;;=4^E11.349
- ;;^UTILITY(U,$J,358.3,58326,2)
- ;;=^5002639
- ;;^UTILITY(U,$J,358.3,58327,0)
- ;;=E11.9^^272^2906^74
- ;;^UTILITY(U,$J,358.3,58327,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58327,1,3,0)
- ;;=3^Type 2 DM w/o Complications
- ;;^UTILITY(U,$J,358.3,58327,1,4,0)
- ;;=4^E11.9
- ;;^UTILITY(U,$J,358.3,58327,2)
- ;;=^5002666
- ;;^UTILITY(U,$J,358.3,58328,0)
- ;;=H35.363^^272^2906^18
- ;;^UTILITY(U,$J,358.3,58328,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58328,1,3,0)
- ;;=3^Drusen of Macular,Bilateral
- ;;^UTILITY(U,$J,358.3,58328,1,4,0)
- ;;=4^H35.363
- ;;^UTILITY(U,$J,358.3,58328,2)
- ;;=^5005660
- ;;^UTILITY(U,$J,358.3,58329,0)
- ;;=H35.362^^272^2906^19
- ;;^UTILITY(U,$J,358.3,58329,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58329,1,3,0)
- ;;=3^Drusen of Macular,Left Eye
- ;;^UTILITY(U,$J,358.3,58329,1,4,0)
- ;;=4^H35.362
- ;;^UTILITY(U,$J,358.3,58329,2)
- ;;=^5005659
- ;;^UTILITY(U,$J,358.3,58330,0)
- ;;=H35.361^^272^2906^20
- ;;^UTILITY(U,$J,358.3,58330,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58330,1,3,0)
- ;;=3^Drusen of Macular,Right Eye
- ;;^UTILITY(U,$J,358.3,58330,1,4,0)
- ;;=4^H35.361
- ;;^UTILITY(U,$J,358.3,58330,2)
- ;;=^5005658
- ;;^UTILITY(U,$J,358.3,58331,0)
- ;;=H04.123^^272^2906^21
- ;;^UTILITY(U,$J,358.3,58331,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58331,1,3,0)
- ;;=3^Dry Eye Syndrome,Bilateral Lacrimal Glands
- ;;^UTILITY(U,$J,358.3,58331,1,4,0)
- ;;=4^H04.123
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3GW 3939 printed Feb 19, 2025@00:14:58 Page 2
- IBDEI3GW ; ; 19-NOV-2015
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,58319,1,4,0)
- +2 ;;=4^E11.321
- +3 ;;^UTILITY(U,$J,358.3,58319,2)
- +4 ;;=^5002634
- +5 ;;^UTILITY(U,$J,358.3,58320,0)
- +6 ;;=E11.329^^272^2906^67
- +7 ;;^UTILITY(U,$J,358.3,58320,1,0)
- +8 ;;=^358.31IA^4^2
- +9 ;;^UTILITY(U,$J,358.3,58320,1,3,0)
- +10 ;;=3^Type 2 DM w/ Mild Nonprolif DM Retinopathy w/o Macular Edema
- +11 ;;^UTILITY(U,$J,358.3,58320,1,4,0)
- +12 ;;=4^E11.329
- +13 ;;^UTILITY(U,$J,358.3,58320,2)
- +14 ;;=^5002635
- +15 ;;^UTILITY(U,$J,358.3,58321,0)
- +16 ;;=E11.331^^272^2906^68
- +17 ;;^UTILITY(U,$J,358.3,58321,1,0)
- +18 ;;=^358.31IA^4^2
- +19 ;;^UTILITY(U,$J,358.3,58321,1,3,0)
- +20 ;;=3^Type 2 DM w/ Mod Nonprolif DM Retinopathy w/ Macular Edema
- +21 ;;^UTILITY(U,$J,358.3,58321,1,4,0)
- +22 ;;=4^E11.331
- +23 ;;^UTILITY(U,$J,358.3,58321,2)
- +24 ;;=^5002636
- +25 ;;^UTILITY(U,$J,358.3,58322,0)
- +26 ;;=E11.339^^272^2906^69
- +27 ;;^UTILITY(U,$J,358.3,58322,1,0)
- +28 ;;=^358.31IA^4^2
- +29 ;;^UTILITY(U,$J,358.3,58322,1,3,0)
- +30 ;;=3^Type 2 DM w/ Mod Nonprolif DM Retinopathy w/o Macular Edema
- +31 ;;^UTILITY(U,$J,358.3,58322,1,4,0)
- +32 ;;=4^E11.339
- +33 ;;^UTILITY(U,$J,358.3,58322,2)
- +34 ;;=^5002637
- +35 ;;^UTILITY(U,$J,358.3,58323,0)
- +36 ;;=E11.351^^272^2906^70
- +37 ;;^UTILITY(U,$J,358.3,58323,1,0)
- +38 ;;=^358.31IA^4^2
- +39 ;;^UTILITY(U,$J,358.3,58323,1,3,0)
- +40 ;;=3^Type 2 DM w/ Prolif DM Retinopathy w/ Macular Edema
- +41 ;;^UTILITY(U,$J,358.3,58323,1,4,0)
- +42 ;;=4^E11.351
- +43 ;;^UTILITY(U,$J,358.3,58323,2)
- +44 ;;=^5002640
- +45 ;;^UTILITY(U,$J,358.3,58324,0)
- +46 ;;=E11.359^^272^2906^71
- +47 ;;^UTILITY(U,$J,358.3,58324,1,0)
- +48 ;;=^358.31IA^4^2
- +49 ;;^UTILITY(U,$J,358.3,58324,1,3,0)
- +50 ;;=3^Type 2 DM w/ Prolif DM Retinopathy w/o Macular Edema
- +51 ;;^UTILITY(U,$J,358.3,58324,1,4,0)
- +52 ;;=4^E11.359
- +53 ;;^UTILITY(U,$J,358.3,58324,2)
- +54 ;;=^5002641
- +55 ;;^UTILITY(U,$J,358.3,58325,0)
- +56 ;;=E11.341^^272^2906^72
- +57 ;;^UTILITY(U,$J,358.3,58325,1,0)
- +58 ;;=^358.31IA^4^2
- +59 ;;^UTILITY(U,$J,358.3,58325,1,3,0)
- +60 ;;=3^Type 2 DM w/ Severe Nonprolif DM Retinopathy w/ Macular Edema
- +61 ;;^UTILITY(U,$J,358.3,58325,1,4,0)
- +62 ;;=4^E11.341
- +63 ;;^UTILITY(U,$J,358.3,58325,2)
- +64 ;;=^5002638
- +65 ;;^UTILITY(U,$J,358.3,58326,0)
- +66 ;;=E11.349^^272^2906^73
- +67 ;;^UTILITY(U,$J,358.3,58326,1,0)
- +68 ;;=^358.31IA^4^2
- +69 ;;^UTILITY(U,$J,358.3,58326,1,3,0)
- +70 ;;=3^Type 2 DM w/ Severe Nonprolif DM Retinopathy w/o Macular Edema
- +71 ;;^UTILITY(U,$J,358.3,58326,1,4,0)
- +72 ;;=4^E11.349
- +73 ;;^UTILITY(U,$J,358.3,58326,2)
- +74 ;;=^5002639
- +75 ;;^UTILITY(U,$J,358.3,58327,0)
- +76 ;;=E11.9^^272^2906^74
- +77 ;;^UTILITY(U,$J,358.3,58327,1,0)
- +78 ;;=^358.31IA^4^2
- +79 ;;^UTILITY(U,$J,358.3,58327,1,3,0)
- +80 ;;=3^Type 2 DM w/o Complications
- +81 ;;^UTILITY(U,$J,358.3,58327,1,4,0)
- +82 ;;=4^E11.9
- +83 ;;^UTILITY(U,$J,358.3,58327,2)
- +84 ;;=^5002666
- +85 ;;^UTILITY(U,$J,358.3,58328,0)
- +86 ;;=H35.363^^272^2906^18
- +87 ;;^UTILITY(U,$J,358.3,58328,1,0)
- +88 ;;=^358.31IA^4^2
- +89 ;;^UTILITY(U,$J,358.3,58328,1,3,0)
- +90 ;;=3^Drusen of Macular,Bilateral
- +91 ;;^UTILITY(U,$J,358.3,58328,1,4,0)
- +92 ;;=4^H35.363
- +93 ;;^UTILITY(U,$J,358.3,58328,2)
- +94 ;;=^5005660
- +95 ;;^UTILITY(U,$J,358.3,58329,0)
- +96 ;;=H35.362^^272^2906^19
- +97 ;;^UTILITY(U,$J,358.3,58329,1,0)
- +98 ;;=^358.31IA^4^2
- +99 ;;^UTILITY(U,$J,358.3,58329,1,3,0)
- +100 ;;=3^Drusen of Macular,Left Eye
- +101 ;;^UTILITY(U,$J,358.3,58329,1,4,0)
- +102 ;;=4^H35.362
- +103 ;;^UTILITY(U,$J,358.3,58329,2)
- +104 ;;=^5005659
- +105 ;;^UTILITY(U,$J,358.3,58330,0)
- +106 ;;=H35.361^^272^2906^20
- +107 ;;^UTILITY(U,$J,358.3,58330,1,0)
- +108 ;;=^358.31IA^4^2
- +109 ;;^UTILITY(U,$J,358.3,58330,1,3,0)
- +110 ;;=3^Drusen of Macular,Right Eye
- +111 ;;^UTILITY(U,$J,358.3,58330,1,4,0)
- +112 ;;=4^H35.361
- +113 ;;^UTILITY(U,$J,358.3,58330,2)
- +114 ;;=^5005658
- +115 ;;^UTILITY(U,$J,358.3,58331,0)
- +116 ;;=H04.123^^272^2906^21
- +117 ;;^UTILITY(U,$J,358.3,58331,1,0)
- +118 ;;=^358.31IA^4^2
- +119 ;;^UTILITY(U,$J,358.3,58331,1,3,0)
- +120 ;;=3^Dry Eye Syndrome,Bilateral Lacrimal Glands
- +121 ;;^UTILITY(U,$J,358.3,58331,1,4,0)
- +122 ;;=4^H04.123